Literature DB >> 32006297

A novel pregnene analogs: synthesis, cytotoxicity on prostate cancer of PC-3 and LNCPa-AI cells and in silico molecular docking study.

Nabeel A Abdul-Rida1, Ali M Farhan1, Najim A Al-Masoudi2,3, Bahjat A Saeed4, Dannah Miller5, Ming-Fong Lin6.   

Abstract

New pregnene analogs of N-hydroxamic acid 6, imino-propane hydrazides 7 and 8 as well as the aryl amides 9-11, oxadiazole, pyrazole and sulfinyl analogs 13-15, via the hydrazide analog 5 of methyl ((5-pregnen-3β,17β-diol-15α-yl)thio)propanoate (4) were synthesized. The in vitro cytotoxic activities of selected synthesized steroids against two human prostate cancer cell lines (PC-3, and LNCaP-AI) were evaluated by MTT assay. Compound 10 was the most active cytotoxic agent among these steroids against PC-3 and LNCaP-AI cell lines with inhibition of 96.2%, and 93.6% at concentration levels of 10.0 μM and 91.8%, and of 79.8% at concentration of 1.0 μM, respectively. Molecular docking study of 10 showed a hydrogen bonding with the amino acid Asn705 residue of the receptor 1E3G, together with hydrophobic interactions. Therefore, compound 10 can be considered as a promising anticancer agent due to its potent cytotoxic activity.

Entities:  

Keywords:  Amides; Anticancer activity; Molecular docking study; Oxadiazole; Pregnene analogs; Pyrazole

Mesh:

Substances:

Year:  2020        PMID: 32006297     DOI: 10.1007/s11030-020-10038-w

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   3.364


  29 in total

Review 1.  The epidemiology of ovarian cancer.

Authors:  R J Edmondson; J M Monaghan
Journal:  Int J Gynecol Cancer       Date:  2001 Nov-Dec       Impact factor: 3.437

Review 2.  Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.

Authors:  William P Harris; Elahe A Mostaghel; Peter S Nelson; Bruce Montgomery
Journal:  Nat Clin Pract Urol       Date:  2009-02

Review 3.  Corticosteroids in the management of prostate cancer: a critical review.

Authors:  Chukwuma Ndibe; Christopher G Wang; Guru Sonpavde
Journal:  Curr Treat Options Oncol       Date:  2015-02

4.  Synthesis and anti-glioma activity of 25(R)-spirostan-3beta,5alpha,6beta,19-tetrol.

Authors:  TianDong Leng; JingXia Zhang; Jun Xie; ShuJia Zhou; YiJun Huang; YueHan Zhou; WenBo Zhu; GuangMei Yan
Journal:  Steroids       Date:  2009-12-21       Impact factor: 2.668

Review 5.  Sex hormones and hypertension.

Authors:  Raghvendra K Dubey; Suzanne Oparil; Bruno Imthurn; Edwin K Jackson
Journal:  Cardiovasc Res       Date:  2002-02-15       Impact factor: 10.787

6.  Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain.

Authors:  A Casimiro-Garcia; E De Clercq; C Pannecouque; M Witvrouw; T L Stup; J A Turpin; R W Buckheit; M Cushman
Journal:  Bioorg Med Chem       Date:  2000-01       Impact factor: 3.641

Review 7.  Steroid sulfatase: a new target for the endocrine therapy of breast cancer.

Authors:  Susannah J Stanway; Patrick Delavault; Atul Purohit; L W Lawrence Woo; Christophe Thurieau; Barry V L Potter; Michael J Reed
Journal:  Oncologist       Date:  2007-04

8.  Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.

Authors:  M Cushman; W M Golebiewski; Y Pommier; A Mazumder; D Reymen; E De Clercq; L Graham; W G Rice
Journal:  J Med Chem       Date:  1995-02-03       Impact factor: 7.446

9.  Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline.

Authors:  X Kostaras; F Cusano; G A Kline; W Roa; J Easaw
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

10.  Study of osteoarthritis treatment with anti-inflammatory drugs: cyclooxygenase-2 inhibitor and steroids.

Authors:  Hongsik Cho; Andrew Walker; Jeb Williams; Karen A Hasty
Journal:  Biomed Res Int       Date:  2015-04-27       Impact factor: 3.411

View more
  1 in total

Review 1.  Targeting treatment options for castration-resistant prostate cancer.

Authors:  Dannah R Miller; Matthew A Ingersoll; Benjamin A Teply; Ming-Fong Lin
Journal:  Am J Clin Exp Urol       Date:  2021-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.